艾滋病毒阳性和艾滋病毒阴性患者的口腔莱什曼病:与两个新病例报告进行比较分析
Ana Cláudia Garcia Rosa1, André Machado de Senna2, Fabrício Passador Santos3
1Federal University of Tocantins, Medicine Course, Palmas, Tocantins, Brazil. anaclaudiagarcia@uft.edu.br.
Head and neck pathology
|August 5, 2024
概括
巴西的粘膜皮肤雷什曼病通常会影响口腔,即使是免疫力低下的人. 这与其他地区的情况形成鲜明对比,在这些地区,口腔莱什曼病表明系统性疾病,这是由于不同的寄生虫物种造成的.
科学领域:
- 传染性疾病 传染性疾病
- 寄生虫学的寄生虫学
- 公共卫生 公共卫生
背景情况:
- 粘膜皮肤雷什曼病 (MCL) 是一种被忽视的热带疾病.
- 在MCL的口腔参与可以根据地理位置和宿主免疫状况显著不同.
- 了解这些变异对于准确的诊断和有效的治疗至关重要.
研究的目的:
- 调查临床表现,诊断,治疗和MCL的主要口腔参与的结果.
- 为了比较巴西艾滋病毒阳性和艾滋病毒阴性患者的病例.
- 将美洲的发现与欧洲,亚洲和非洲的发现进行对比.
主要方法:
- 在巴西对MCL患者的病例报告分析.
- 口腔病变的临床和组织病理学检查.
- 基于艾滋病毒状况和地理区域的临床进展模式的比较分析.
- 对不同地区涉及的寄生虫物种的审查.
主要成果:
- 在巴西 (美洲),MCL经常呈现局部口腔病变,无论系统性免疫抑制.
- 在欧洲,亚洲和非洲,口腔莱什曼病通常与免疫功能低下患者的内脏莱什曼病有关.
- 观察到的差异归因于致病性Leishmania寄生虫物种的变异.
结论:
- 区域和免疫学因素对MCL的呈现有显著影响.
- 准确的诊断和管理需要考虑地理来源和宿主免疫状态.
- 对于这种被忽视的疾病,对寄生虫与宿主相互作用的进一步研究是有必要的.
相关概念视频
Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Amebiasis
Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...


